US 11015200
Antisense-induced exon exclusion in myostatin
granted A61KA61K31/7105A61P
Quick answer
US patent 11015200 (Antisense-induced exon exclusion in myostatin) held by Sarepta Therapeutics, Inc. expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7105, A61P, A61P21/00